Squarepoint Ops LLC Forma Therapeutics Holdings, Inc. Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$5.1 - $10.0 $69,421 - $136,120	13,612 Added 97.72%	27,541 $190,000
Q1 2022 May 16, 2022	SELL	$8.34 - $14.69 $15,003 - $26,427	-1,799 Reduced 11.44%	13,929 $130,000
Q4 2021 Feb 14, 2022	BUY	$13.6 - $24.89 $213,900 - $391,469	15,728 New	15,728 $224,000
Q3 2021 Nov 15, 2021	SELL	$21.22 - $25.7 $453,577 - $549,337	-21,375 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$22.86 - $30.95 $488,632 - $661,556	21,375 New	21,375 $532,000
Q1 2021 May 17, 2021	SELL	$24.58 - $42.82 $308,331 - $537,134	-12,544 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$34.9 - $51.08 $437,785 - $640,747	12,544 New	12,544 $438,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.